Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move
(TSXV: $KHRN.V) (TSXV: $RIV.V) (TSX: $TRST.TO) (CSE: $THC.C)
Delta, Kelowna, BC –June
19, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news
source covering leading sectors including marijuana and hemp stocks and its
potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com “potcasts”,
looking at cannabis news, stocks to watch as well as insights from thought
leaders and experts.
Today we are looking at a few early
announcements.
Khiron Life
Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF), a cannabis company with core operations
in Latin America, announced that it has completed the acquisition of
NettaGrowth International Inc., previously announced on January 25, 2019 and
April 9, 2019, and its wholly-owned subsidiary Dormul S.A., a Uruguayan company
that has obtained the first licence to produce and export medical cannabis with
THC for commercialization in Uruguay. As consideration for the acquisition of
NettaGrowth, Khiron has issued 8,498,821 common shares to the shareholders of
NettaGrowth at a deemed price of $1.61 per common share.
Alvaro
Torres, Khiron CEO and Director, comments " Closing of the acquisition of
Nettagrowth represents an important milestone for Khiron. With this deal we
expand our geographic footprint into a market we know well, and secure access
to potential patients in Uruguay and in Southern Brazil.
Uruguay
was the first country to establish legislation for cannabis and Dormul has
secured a medical cannabis cultivation and commercialization licence for the
jurisdiction, with a cultivation capacity of up to 120 tonnes and 170,000
plants. In addition, Dormul has an application pending for an extraction
licence. Upon receipt of its extraction licence, Dormul is expected to be among
the first companies in Uruguay to be approved for medical cannabis-based CBD
oils for both domestic and export purposes. With a strong commitment to
research and development, Dormul has established a strategic partnership with
the Institut Pasteur de Montevideo, a
prestigious foundation formed between the Uruguayan and French governments
focused on the research and development of cannabis product. The foundation was
recently recognized by the Uruguayan Ministry of Industry for the important
social and economic impact its operations are anticipated to have for the
country.
Canopy Rivers Inc. (TSXV:
RIV) (OTC:
CNPOF) and ZeaKal, Inc. announced an
investment and strategic collaboration between Canopy Rivers and ZeaKal, a California-based plant science innovator with proprietary
technologies that sustainably increase photosynthesis, improve plant yield and
enhance nutritional profiles for a variety of agricultural crops. The
investment from Canopy Rivers marks another significant corporate milestone
this calendar year for ZeaKal, following the February announcement of its
R&D collaboration with Corteva
Agriscience (NYSE:
CTVA), the recently spun-out and NYSE-listed
agricultural science division of DowDuPont.
ZeaKal's proprietary technology,
PhotoSeed™, increases a plant's intrinsic photosynthetic capacity, meaning that
PhotoSeed™ plants can convert more sunlight and carbon dioxide into energy for
growth. This results in substantial improvement in seed and grain yield, as
well as improved macronutrient profiles that drive an increase in both oil and
protein content. For farmers, this means better productivity and profit
margins; for consumers, this means higher nutritional profiles and an
environmentally friendly way to meet growing global demand. With multi-year field trials across diverse
plant species in the United States, Canada and New Zealand, the initial
commercial focus has been on major row crops. Following Canopy Rivers'
investment, ZeaKal intends to expand its program to include cannabis and hemp.
"Our investment in ZeaKal, the fifth
consecutive international transaction for Canopy Rivers, builds on our thesis
of selecting globally scalable and innovative processes, products, and
technologies from complementary industries, and applying them to the cannabis
and hemp economy," said Mary Dimou, Director of Business Development at
Canopy Rivers. "Plant sciences is a mostly overlooked but absolutely
critical segment of the cannabis and hemp value chain, and we are seeking to
address this gap with this investment. ZeaKal's technology has already realized
success across a number of crops during field trials, and these are crops that
have been commercialized for decades. The application of this innovative
technology throughout the Canopy Rivers portfolio and the cannabis and hemp
industry at large could be a game changer."
Canopy Rivers believes that ZeaKal's
PhotoSeed™ technology has the potential to translate into significant benefits
for the cannabis and hemp industry. Due to prohibition, the cultivation of
cannabis and hemp has lacked the agricultural research and advancements that
have significantly improved the cultivation of other crops. Canopy Rivers
believes that applying ZeaKal's PhotoSeed™ technology to cannabis and hemp represents
a significant step forward - with increased crop yield, higher oil production,
additional grow cycles, and enriched cannabinoid output numbering among the
potential benefits of the technology. While trials on cannabis and hemp have
yet to begin, the positive results already achieved give Canopy Rivers
confidence in ZeaKal's experienced team and its ability to successfully
optimize and adapt its technology for expansion into this industry.
CannTrust Holdings Inc. (TSX:
TRST) (NYSE:
CTST), a federally regulated licensed
producer of medical and recreational cannabis with more than 72,000 patients in
Canada, announced that
it is establishing operations in the United States ("U.S."), starting
in the State of California. CannTrust has signed a non-binding letter of intent
that will provide access to over 3,000 acres of farmland for hemp production
with Elk Grove Farming Company, LLC, a diversified farming company with
operations in the State of California, to secure low-cost hemp with high CBD
content. CannTrust and Elk Grove will each have 50% ownership of a new entity.
The opportunity in the U.S. for CannTrust
is to become a trusted supplier of consistent, standardized and high-quality
hemp-derived CBD formulations at scale. The Company believes there will be
increasing demand for hemp-derived CBD formulations from international
retailers and product manufacturers, and those organizations require expertise
in genetics and value-add processing to ensure products are desirable and meet
the highest safety standards.
CannTrust will guarantee the off-take of
biomass produced by the Joint Venture, and will use its expertise to process,
formulate and sell hemp-derived CBD products in U.S. markets where such sales
are lawful. As an experienced operator meeting rigorous regulatory standards,
CannTrust is well positioned to execute on this cultivation, processing and
formulation strategy with the goal of becoming a leading supplier of
hemp-derived CBD products in the U.S.
"This agreement represents another
bold move for CannTrust. Our U.S. operation is expected to deliver a
significant increase in low-cost production capacity, which will leverage our
expertise in standardized CBD-based product formulation, and will give the
Company a foothold in the largest international CBD market in the world with an
experienced and knowledgeable partner," said Peter Aceto, Chief Executive
Officer. "Following our successful equity offering, we have the liquidity
we need to fund our ambitious growth plans including our greenhouse expansion
in Niagara, our outdoor cultivation operation in British Columbia, our global
footprint expansion and now our U.S. operation. We continue to focus on
delivering on our vision of becoming a global provider of innovative
cannabis-based and hemp-derived products."
THC BioMed Intl Ltd. (CSE:
THC) announced
that has placed an order for biodegradable filters for its
automated pre-rolls.
The filters are natural, rapidly
degrading and commercial-quality, using raw materials that include flax,
cotton, and manila hemp with no artificial compounds.
The manufacturer advises that the average
time for degradation of these patented filters is 3 days in compost or 2
minutes when dispersed in water at 150 rpm agitation. In comparison, it can
take up to 15 years for common acetate filters to degrade.
The filters are designed to comply with
single-use plastic bans, which are already in place in Europe, are coming into
effect in Vancouver B.C. in 2020 and are being discussed for eventual adoption
in other parts of Canada.
THC clarifies the filters are there only
for convenience purposes to stop loose cannabis from going into a user's mouth.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news release,
content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use
of cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment